Skip to main content
See every side of every news story
Published • loading... • Updated

One Study Analyzes the Genetic Variations of Patients with Breast Cancer Who Are More at Risk of Developing a Serious Side Effect From a Drug.

Summary by informacion.es
The PROCURE project, a study involving 27 hospitals throughout Spain, has identified genes related to the risk of developing pneumonitis - one of the most serious toxicities caused by inflammation of lung tissue - in patients with breast cancer treated with the innovative drug trastuzumab deruxtecan (T-DXd).
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

elcorreogallego.eselcorreogallego.es
+3 Reposted by 3 other sources

The PROCURE project, a study involving 27 hospitals throughout Spain, has identified genes related to the risk of developing pneumonitis - one of the most serious toxicities caused by inflammation of lung tissue - in patients with breast cancer treated with the innovative drug trastuzumab deruxtecan (T-DXd).

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

informacion.es broke the news on Friday, October 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal